Literature DB >> 25091118

Applications of lipid based formulation technologies in the delivery of biotechnology-based therapeutics.

Lissinda H du Plessis, Etienne B Marais, Faruq Mohammed, Awie F Kotzé1.   

Abstract

In the last decades several new biotechnologically-based therapeutics have been developed due to progress in genetic engineering. A growing challenge facing pharmaceutical scientists is formulating these compounds into oral dosage forms with adequate bioavailability. An increasingly popular approach to formulate biotechnology-based therapeutics is the use of lipid based formulation technologies. This review highlights the importance of lipid based drug delivery systems in the formulation of oral biotechnology based therapeutics including peptides, proteins, DNA, siRNA and vaccines. The different production procedures used to achieve high encapsulation efficiencies of the bioactives are discussed, as well as the factors influencing the choice of excipient. Lipid based colloidal drug delivery systems including liposomes and solid lipid nanoparticles are reviewed with a focus on recent advances and updates. We further describe microemulsions and self-emulsifying drug delivery systems and recent findings on bioactive delivery. We conclude the review with a few examples on novel lipid based formulation technologies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25091118     DOI: 10.2174/1389201015666140804163143

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  3 in total

1.  Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants.

Authors:  Sita Awasthi; Lauren M Hook; Gokul Swaminathan; Tina M Cairns; Benjamin Brooks; Jeffrey S Smith; Noah T Ditto; Marian E Gindy; Andrew J Bett; Amy S Espeseth; Gary H Cohen; Harvey M Friedman
Journal:  Vaccine       Date:  2019-05-29       Impact factor: 3.641

2.  Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.

Authors:  Bader B Alsulays; Md Khalid Anwer; Gamal A Soliman; Sultan M Alshehri; El-Sayed Khafagy
Journal:  Int J Nanomedicine       Date:  2019-11-25

3.  A toxicity profile of the Pheroid® technology in rodents.

Authors:  Janke Kleynhans; Dale Elgar; Thomas Ebenhan; Jan Rijn Zeevaart; Awie Kotzé; Anne Grobler
Journal:  Toxicol Rep       Date:  2019-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.